Clinical Trial Update: A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the biological activity of the antibody R1507 in women with operable breast cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• R1507

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED